Deutsche Bank’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$384K Buy
124,516
+44,576
+56% +$189K ﹤0.01% 2712
2025
Q4
$289K Buy
79,940
+3,047
+4% +$13.3K ﹤0.01% 2842
2025
Q3
$290K Buy
76,893
+6,122
+9% +$23.6K ﹤0.01% 2872
2025
Q2
$274K Sell
70,771
-9,080
-11% -$49.1K ﹤0.01% 2788
2025
Q1
$399K Buy
79,851
+3,026
+4% +$19.2K ﹤0.01% 2602
2024
Q4
$554K Buy
76,825
+21,033
+38% +$161K ﹤0.01% 2556
2024
Q3
$343K Buy
55,792
+15,357
+38% +$104K ﹤0.01% 2656
2024
Q2
$269K Sell
40,435
-3,153
-7% -$23.3K ﹤0.01% 2652
2024
Q1
$444K Sell
43,588
-17,298
-28% -$176K ﹤0.01% 2411
2023
Q4
$685K Buy
60,886
+30,458
+100% +$127K ﹤0.01% 2224
2023
Q3
$79.1K Buy
+30,428
New +$87.3K ﹤0.01% 3264
2022
Q2
Sell
-21,646
Closed -$132K 4124
2022
Q1
$132K Sell
21,646
-2,438
-10% -$18K ﹤0.01% 3470
2021
Q4
$221K Buy
24,084
+1,282
+6% +$13.6K ﹤0.01% 3332
2021
Q3
$258K Buy
22,802
+3,508
+18% +$42.7K ﹤0.01% 3432
2021
Q2
$190K Buy
+19,294
New +$264K ﹤0.01% 3814
2019
Q3
Sell
-100
Closed 4852
2019
Q2
$0 Hold
100
﹤0.01% 5266
2019
Q1
$0 Buy
100
+99
+9,900% +$295 ﹤0.01% 5153
2018
Q4
$0 Hold
1
﹤0.01% 5139
2018
Q3
$0 Hold
1
﹤0.01% 5336
2018
Q2
$0 Hold
1
﹤0.01% 5389
2018
Q1
$0 Sell
1
-2,904
-100% -$146K ﹤0.01% 5367
2017
Q4
$173K Sell
2,905
-534
-16% -$34.1K ﹤0.01% 4092
2017
Q3
$239K Sell
3,439
-571
-14% -$42.5K ﹤0.01% 3796
2017
Q2
$384K Buy
4,010
+3,730
+1,332% +$620K ﹤0.01% 3597
2017
Q1
$67K Sell
280
-2,650
-90% -$1.42M ﹤0.01% 4103
2016
Q4
$2.85M Buy
2,930
+1,749
+148% +$1.57M ﹤0.01% 2025
2016
Q3
$1.03M Buy
1,181
+728
+161% +$571K ﹤0.01% 2813
2016
Q2
$330K Buy
+453
New +$310K ﹤0.01% 3505
2015
Q1
Sell
-11
Closed -$5K 5098
2014
Q4
$5K Buy
+11
New +$5.65K ﹤0.01% 5864
2014
Q2
Sell
-2
Closed -$1K 5864
2014
Q1
$1K Buy
+2
New +$1.17K ﹤0.01% 5409
2013
Q4
Sell
-445
Closed -$280K 5380
2013
Q3
$280K Buy
+445
New +$255K ﹤0.01% 3896

Other funds holding ALT

Deutsche Bank's ALT Position: Q1 2026 in Review

Deutsche Bank increased its Altimmune (ALT) stake by 56% in Q1 2026, buying an estimated $189K and bringing the position to 124,516 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

Deutsche Bank first reported a position in ALT in Q3 2013 and has held it in 31 quarters since. The position peaked at $2.85M in Q4 2016. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Deutsche Bank held 124,516 shares of Altimmune worth $384K as of Q1 2026.
  • Deutsche Bank bought 44,576 Altimmune shares in Q1 2026, an estimated $189K.
  • Altimmune made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2712 holding.
  • Deutsche Bank first reported a position in Altimmune in Q3 2013 and has held it in 31 quarters since.
  • Deutsche Bank's Altimmune position peaked at $2.85M in Q4 2016.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.